EDGAR Filing Documents for 0000950115-99-001007

Form S-1 - General form for registration of securities under the Securities Act of 1933:

SEC Accession No. 0000950115-99-001007

Filing Date

1999-07-12

Accepted

1999-07-12 00:00:00

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	INITIAL STATEMENT		S-1	317494
2	BYLAWS OF THE COMPANY		EX-3.2	23702
3	FORM OF COMMON STOCK CERTIFICATE		EX-4.1	3631
4	FORM OF SPECIAL VOTING RIGHTS		EX-4.2	9641
5	1998 INCENTIVE STOCK OPTION PLAN		EX-4.3	27334
6	1999 INCENTIVE STOCK OPTION PLAN		EX-4.3.1	54
7	FORMS OF COLEMAN SECURITIES SERIES		EX-4.4.1	27472
8	REGISTRATION RIGHTS AGREEMENT		EX-4.6	69066
9	OPINION OF ECKERT SEAMANS CHERMIN & MELLOT, LLC		EX-5	50
10	SUBSIDIARIES OF THE REGISTRANT		EX-21	733
11	CONSENT OF WITHUM, SMITH & BROWN		EX-23.1.1	844
12	CONSENT OF MINTZ & PARTNERS		EX-23.1.2	512
13	FINANCIAL DATA SCHEDULES		EX-27	3279
	Complete submission text file	0000950115-99-001007.txt		486504

Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1

Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551

GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)